Martin Steven Robert 4
4 · APRICUS BIOSCIENCES, INC. · Filed Dec 20, 2012
Insider Transaction Report
Form 4
Martin Steven Robert
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2012-12-18+75,000→ 75,000 totalExercise: $2.04Exp: 2022-12-18→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The option shall vest with respect to one-fourth of the underlying shares upon the first anniversary of the grant date, and then with respect to the remaining shares monthly thereafter over the next four years so the option will be fully vested as of 12/18/2016.